Keywords
integrative medicine
European Union
legislation
patient safety
Abstract
IN EUROPEAN UNION MEMBER STATES. NARRATIVE REVIEWDERS BETWEEN INTEGRATIVE MEDICINE AND EBM: SIGNIFICANCE, POTENTIAL FOR USE AND LEGAL ISSUES
Aim. The aim of the study is to present the meaning, potential of use and legal issues related to the use of complementary, alternative and integrative medicine in the European Union member states.
Material and methods. Non-systematic review. Analysis of the literature on the subject covering the issues related to using and legal issues of complementary and alternative medicine methods in the context of the integration of Evidence Based Medicine methods into conventional medicine.
Results. Despite attempts to introduce restrictions and introduce legal regulations regarding the use of unconventional medicine, it is still common to use unconfi rmed methods, based on information searched on the Internet or using the services of people without any education in a given fi eld. Lack of or insuffi cient regulations to manage the quality, safety and eff ectiveness of complementary and alternative medicine methods, and the lack of integration between the health care system and CAM pose the greatest risk.
Conclusions. Due to the ever-increasing public demand for the use of complementary medicine methods, it is necessary to Take steps to introduce integrative medicine that will ensure safe and eff ective patient-centered care, taking into account the comparability and availability of CAM practices in European Union member states.
References
1. WHO global report on traditional and complementary medicine 2019. Accessed September 8, 2021. https://www.who.int/publications/i/item/978924151536.
2. Complementary, Alternative, or Integrative Health: What’s In a Name? | NCCIH. Accessed September 27, 2021. https://www.nccih.nih.gov/health/complementaryalternative-or-integrative-health-whats-in-a-name.
3. Barry CA. The role of evidence in alternative medicine: Contrasting biomedical and anthropological approaches. Soc. Sci. Med. 2006; 62(11): 2646-2657.
4. Wang CC, Geale SK. The power of story: Narrative inquiry as a methodology in nursing research. Int. J. Nurs. 2015, 2(2); 195-198.
5. Hegyi G, Petri RP, Sarsina PR, et al. Overview of Integrative Medicine Practices and Policies in NATO Participant Countries. Med. Acupunct. 2015; 27(5): 318.
6. Kwon JH, Lee SC, Lee MA, et al. Behaviors and attitudes toward the use of complementary and alternative medicine among Korean cancer patients. Cancer Res Treat. 2019; 51(3): 851-860.
7. Eisele G, Roelcke U, Conen K, et al. Complementary and alternative medicine use by glioma patients in Switzerland. Neuro-Oncology Pract. 2019; 6(3): 237-244.
8. Johnson SB, Parson M, Dorff T, et al. Cancer Misinformation and Harmful Information on Facebook and Other Social Media: a Brief Report. J. Natl. Cancer Inst. 2021; 22:djab141. doi: 10.1093/jnci/djab141
9. Garrett B, Murphy S, Jamal S, et al. Internet health scams-Developing a taxonomy and risk-of-deception assessment tool. Health Soc. Care. Community. 2019; 27(1): 226-240.
10. Bauchner H. Trust in Health Care. JAMA. 2019; 321(6): 547.
11. Johnson SB, Park HS, Gross CP, et al. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers. JAMA Oncol. 2018; 4(10):1375-1381.
12. Johnson SB, Park HS, Gross CP, et al. Use of Alternative Medicine for Cancer and Its Impact on Survival. JNCI J Natl Cancer Inst. 2018; 110(1): 121-124.
13. WHO traditional medicine strategy: 2014-2023. Accessed September 9, 2021. https://www.who.int/publications/i/item/9789241506096
14. Wiesener S, Salamonsen A, Fønnebø V. Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe? BMC Complement Altern Med. 2018; 18(1): 1-7.
15. Alsanad SM, Howard RL, Williamson EM. An assessment of the impact of herb-drug combinations used by cancer patients. BMC Complement Altern Med. 2016; 16(1): 1-9.
16. Fischer F, Lewith G, Witt CM, et al. a Research Roadmap for Complementary and Alternative Medicine -What We Need to Know by 2020. Complement Med. Res. 2014; 21(2): e1-e16.
17. Xu LP, Yang SL, Su SQ, et al. Effect of wrist-ankle acupuncture therapy combined with auricular acupuncture on cancer pain: a four-parallel arm randomized controlled trial. Complement Ther. Clin. Pract. 2020; 39: 101170.
18. Kok ET, Jong MC, Gravendeel B, et al. Resistance to Antibiotics and Antifungal Medicinal Products: Can Complementary and Alternative Medicine Help Solve the Problem in Common Infection Diseases? The Introduction of a Dutch Research Consortium. Evid Based Complement Alternat Med. 2015; 2015: 1-6.
19. Eardley S, Bishop FL, Prescott P, et al. a Systematic Literature Review of Complementary and Alternative Medicine Prevalence in EU. Complement Med. Res. 2012; 19(2): 18-28.
20. Jędrzejewska A, Ślusarska BJ, Szadowska-Szlachetka Z, et al. Use of complementary and alternative medicine in patients with cancer and their relationship with health behaviours – Cross-sectional study. Annals Agric. Environ. Med. 2021; 28(3): 475-482.
21. Buckner CA, Lafrenie RM, Dénommée JA, et al. Complementary and alternative medicine use in patients before and after a cancer diagnosis. Curr. Oncol. 2018; 25(4): e275-e281.
22. Abuelgasim KA, Alsharhan Y, Alenzi T, et al. The use of complementary and alternative medicine by patients with cancer: Af cross-sectional survey in Saudi Arabia. BMC Complement Altern Med. 2018; 18(1): 88.
23. Edwards GV, Aherne NJ, Horsley PJ, et al. Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy. Asia Pac. J. Clin. Oncol. 2014; 10(4): 346-353.
24. Al-Naggar RA, Bobryshev YV, Abdulghani M, et al. Complementary/alternative medicine use among cancer patients in Malaysia. World J. Med. Sci. 2013; 8(2): 157164.
25. Dhanoa A, Yong TL, Yeap SJL, et al. Complementary and alternative medicine use amongst Malaysian orthopaedic oncology patients. BMC Complement Altern Med. 2014; 14(1): 404.
26. Oyunchimeg B, Hwang JH, Ahmed M, et al. Complementary and alternative medicine use among patients with cancer in Mongolia: a National hospital survey. BMC Complement Altern Med. 2017; 17(1): 1-8.
27. Demir BD, Erol O. Complementary and Alternative Medicine Use among Turkish Cancer Patients and the Influencing Factors. Int. J. of Caring Sciences. 2018; 11(1): 319-332.
28. Dogu GG, Kargi A, Tanriverdi O, et al. Complementary/Alternative Medicine Experience in Cancer Patients: a Questionnaire-Based Survey. Int. J. Hematol. Oncol. Artic. 2014; 21(1): 45-53.
29. Üstündağ S, Demir Zencirci A. Complementary and Alternative Medicine Use Among Cancer Patients and Determination of Affecting Factors: a Questionnaire Study. Holist. Nurs. Pract. 2015; 29(6): 357-369.
30. Jermini M, Dubois J, Rodondi PY. Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre. Sci. Rep. 2019; 9 (5078): 1-11.
31. Davis EL, Oh B, Butow PN, et al. Cancer Patient Disclosure and Patient-Doctor Communication of Complementary and Alternative Medicine Use: a Systematic Review. Oncologist. 2012; 17(11): 1475.
32. Chang KH, Brodie R, Choong MA, et al. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer. 2011; 11(1): 196.
33. Stan DL, Wahner-Roedler DL, Yost KJ, et al. Absent and Discordant Electronic Health Record Documentation of Complementary and Alternative Medicine in Cancer Care. J. Altern Complement Med. 2018; 24(9-10): 988-995.
34. Horneber M, Bueschel G, Dennert G, et al. How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr. Cancer Ther. 2012; 11(3): 187-203.
35. Broom A, Wijewardena K, Sibbritt D, et al The use of traditional, complementary and alternative medicine in Sri Lankan cancer care: Results from a survey of 500 cancer patients. Public Health. 2010; 124(4): 232-237.
36. Aliyu UM, Awosan KJ, Oche MO, et al. Prevalence and correlates of complementary and alternative medicine use among cancer patients in Usmanu Danfodiyo university teaching hospital, Sokoto, Nigeria. Niger J. Clin. Pract. 2017; 20(12): 1576-1583.
37. Liao Y-H, Li C-I, Lin C-C, et al. Traditional Chinese medicine as adjunctive therapy improves the long-term survival of lung cancer patients. J. Cancer Res. Clin. Oncol. 2017; 143(12): 2425-2435.
38. Gannotta R, Malik S, Chan AY, et al. Integrative Medicine as a Vital Component of Patient Care. Cureus. 2018; 10(8): e3098.
39. Maizes V, Rakel D, Niemiec C. Integrative Medicine and Patient-Centered Care. EXPLORE. 2009; 5(5): 277-289.
40. Greenlee H, Balneaves LG, Carlson LE, et al. Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer. JNCI Monogr. 2014; 2014(50): 346-358.
41. New EU4Health Programme. Accessed September 9, 2021. https://ec.europa.eu/ commission/presscorner/detail/en/qanda_20_956.
42. Raposo VL. Complementary and alternative medicine, medical liability and the proper standard of care. Complement Ther. Clin. Pract. 2019; 35: 183-188.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Authors